Angiotensin-
Angiotensin- 是目前在国外临床研究中出现的一款新药或疗法，主要研究方向为Obesity、Hypertension。下面汇总了它当前在全球正在招募患者的研究，以及中国患者可以走的申请途径。
24 项
全球在招研究
9 项
已进入 III/IV 期
24 个
开展国家和地区
有
中国境内设点
药品与企业信息
研发企业
- Milton S. Hershey Medical Center
- Assistance Publique - Hôpitaux de Paris
- Hospices Civils de Lyon
- The Searle Company Limited Pakistan
- National Medical Research Center for Cardiology, Ministry of Health of Russian Federation
- Niek Wijnen
- Sherief Abd-Elsalam
- Evi Liliek Wulandari
汇总自相关试验登记的主要申办方；研究机构申办时会显示相应机构名称。
生产企业
公开药品批准资料或正式说明书暂未提供明确的生产企业信息。
研发企业与生产企业可能不是同一家。研究阶段药品可能尚未公布生产企业；生产企业仅取自美国上市原研药说明书所列企业（不含仿制药），不作推测；仅在其他国家上市的药品暂无法显示。
主要开展国家和地区
法国、Pakistan、Russia、荷兰、Egypt、Indonesia、India、美国、英国、Turkey (Türkiye)、丹麦、澳大利亚
正在招募患者的 Angiotensin- 研究
Blood Pressure Reduction to Limit the Evolution of Vascular Brain Lesions in Elderly Individuals
IV 期招募中法国NCT02472028Blockade of the Renin-angiotensin-aldosterone System in Patients With ARVD
II 期招募中法国NCT03593317Clinical Response of EXTOR (Amlodipine/Valsartan) in Newly Diagnosed Hypertensive Patients.
不适用招募中PakistanNCT06625346Triple Combination Therapy (ARNI, SGLT2i, MRA) in Advanced HFpEF
II 期招募中RussiaNCT06655480Radioembolization With Intra-arterial Angiotensin II to Improve Tumor-absorbed Dose (RADIANT)
II 期招募中荷兰NCT07312292Statins and ARBs on Rheumatoid Activity
III 期招募中EgyptNCT03770702Single and Twice-daily Dosing of Ramipril on Renal Function in Chronic Kidney Disease Patients With Reduced Ejection Fraction Heart Failure
IV 期招募中IndonesiaNCT07259512Comparative Effectiveness of Dual Antihypertensive Regimens in Patients After Percutaneous Coronary Intervention
不适用招募中RussiaNCT07683585Which of the Commonly Available and Approved Drugs in Addition to Standard of Care Can Significantly Improve the Slope of Estimated Glomerular Filtration Rate at Two Years When Compared to Standard of Care Alone in South-Asian Kidney Biopsy-proven Adult (≥18 Years) Primary IgA Nephropathy?
IV 期招募中IndiaNCT06676384Role of Sympathetic Overactivity and Angiotensin II in PTSD and CV
II 期招募中美国NCT02560805The Effect of Vasopressor Therapy on Renal Perfusion in Septic Shock
不适用招募中英国NCT06234592Short-Term Effects of Antihypertensive Drugs on Postural Balance and Fall Risk
不适用招募中Turkey (Türkiye)NCT07099677A Study to Determine the Preferred Dose of the Drug, Lisinopril, for Preventing Urinary Toxicity Following Radiotherapy for Prostate Cancer
早期 I 期招募中美国NCT05530655Effects of Percutaneous Transluminal Renal Angioplasty of Atherosclerotic Renal Artery Stenosis in High-Risk Patients.
不适用招募中丹麦NCT05834803Persistent Cardiovascular Effects of COVID-19 Viral Infection Trial (PERCEIVE)
不适用招募中澳大利亚NCT04983823Pharmacological Optimization in Prevention in Heart Failure: A Sex-gap?
IV 期招募中意大利NCT07295522Improving Kidney Care in Type 2 Diabetes: A Study of Pharmacist Prescribing Versus Usual Care
不适用招募中加拿大NCT07169422A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria
III 期招募中美国Argentina澳大利亚奥地利NCT05457283Role of Coenzyme Q10 in Chronic Kidney Disease
IV 期招募中EgyptNCT05942027Mechanisms of Pregnancy Vascular Adaptations
不适用招募中美国NCT03806283Reducing Cardiac-surgery Associated Acute Kidney Injury Occurence by Administering Angiotensin II
III 期招募中德国NCT06615102Effect of Sacubitril/Valsartan on Cardiac Function in Hypertensive Patients Stratified by BMI: A Real World Study
不适用招募中中国NCT05498675Vascular Effects of High-Salt After Preeclampsia
早期 I 期招募中美国NCT06749418Delayed Initiation of ARNI and SGLT2i in Heart Failure With Corrected Aetiology (DELAY-HF), Pilot Study
IV 期招募中South KoreaNCT07572032
中国患者怎么争取用上这款药
这款药已经有研究在中国境内设点，可以先带完整病历去对应医院咨询入组；同时也可以并行了解下面几条途径，多一条备选。
查看完整申请指南同类方向的其他在研新药
本页信息整理自 ClinicalTrials.gov 公开登记数据，仅供参考，不构成医疗建议；是否适合使用该药物，请以专业医生和研究团队的意见为准。